A risk stratification model modified from the U.S. guideline could be applied in an Asian population with or without ASCVD: Validation study.
Hsiao YC, Lee TL, Lin FJ, Hsuan CF, Yeh CF, Chang WT, Kao HL, Jeng JS, Wu YW, Hsieh IC, Fang CC, Wang KY, Chang KC, Lin TH, Sheu WH, Li YH, Yin WH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary and Primary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE & T-PPARCLE) Registries Investigators.
Hsiao YC, et al.
Biomed J. 2024 Jun;47(3):100653. doi: 10.1016/j.bj.2023.100653. Epub 2023 Aug 12.
Biomed J. 2024.
PMID: 37579816
Free PMC article.